InMode Ltd. (NASDAQ:INMD) Given Average Recommendation of "Hold" by Analysts

InMode Ltd. (NASDAQ:INMD - Get Free Report) has been given an average recommendation of "Hold" by the six research firms that are covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $22.60.

INMD has been the topic of several research analyst reports. Needham & Company LLC restated a "hold" rating on shares of InMode in a research report on Thursday, October 31st. Barclays dropped their price objective on shares of InMode from $29.00 to $27.00 and set an "overweight" rating for the company in a report on Monday, October 14th. Finally, BTIG Research initiated coverage on InMode in a research note on Thursday, October 17th. They issued a "buy" rating and a $25.00 target price on the stock.

InMode Stock Performance

InMode stock traded up $0.66 during midday trading on Monday, hitting $18.79. 614,153 shares of the company's stock were exchanged, compared to its average volume of 1,316,356. The stock has a 50-day moving average price of $17.81 and a two-hundred day moving average price of $17.49. InMode has a 52-week low of $14.87 and a 52-week high of $26.80. The company has a market cap of $1.58 billion, a P/E ratio of 9.80 and a beta of 2.07.

Institutional Trading of InMode

Hedge funds and other institutional investors have recently modified their holdings of the business. Franklin Resources Inc. grew its holdings in InMode by 4.6% in the third quarter. Franklin Resources Inc. now owns 17,559 shares of the healthcare company's stock worth $292,000 after purchasing an additional 768 shares during the period. Tidal Investments LLC raised its stake in InMode by 4.6% during the third quarter. Tidal Investments LLC now owns 71,039 shares of the healthcare company's stock valued at $1,204,000 after buying an additional 3,140 shares during the last quarter. Virtu Financial LLC bought a new stake in InMode in the third quarter worth $219,000. Geode Capital Management LLC grew its stake in shares of InMode by 0.6% in the third quarter. Geode Capital Management LLC now owns 1,101,951 shares of the healthcare company's stock worth $18,678,000 after acquiring an additional 6,282 shares during the last quarter. Finally, Disciplined Growth Investors Inc. MN increased its holdings in shares of InMode by 0.4% during the third quarter. Disciplined Growth Investors Inc. MN now owns 808,149 shares of the healthcare company's stock valued at $13,698,000 after acquiring an additional 3,191 shares in the last quarter. 68.04% of the stock is owned by hedge funds and other institutional investors.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.